The objective of this study is to evaluate solCD44 and TP levels in 150 participants with high cancer risk during annual visits over 4 years and to follow prospectively to determine if CD44 and TP are effective early biomarkers for OOPSCC and other cancers. The gene discussed is CD44; the disease is cancer.